Healthcare

According to a market report by Lucintel, the future of the 3D bioprinting market looks promising with opportunities in pharmaceutical & biotechnology and research organizations & academic institutes. The global 3D bioprinting market is expected to reach an estimated $5.0 billion by 2028 with a CAGR of 18.4% from 2023 to 2028. The major drivers for this market are growing demand for organ transplantation, rise in public and private funding to support research activities, and increasing usage of 3D bioprinting in cosmetic surgeries and drug discovery process.



In this market, 3D bioprinters, biomaterials, and scaffolds are the major segments by product. Lucintel forecasts that 3D bioprinters will remain the largest product segment over the forecast period due to the increasing number of clinical trials and drug testing process, which will help in significantly reducing animal testing. 



Within this market, research organizations & academic institutes are expected to remain the largest end use industry segment due to the expanding research into portable 3D bioprinting technology that can be used to conveniently generate skin tissues and reduce scars in trauma care. 



North America will remain the largest region due to growing prevalence of chronic diseases, sophisticated healthcare infrastructure along with high disposable income levels in the region, and extensive research activities.

Organovo Holdings, Envisiontec, Nano 3D Biosciences, Cyfuse Biomedical, and Regenhu are the major suppliers in the global 3D bioprinting market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global 3D bioprinting market by technology, product, material, application, end use industry, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global 3D Bioprinting Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global 3D bioprinting market by technology, product, material, application, end use industry, and region, as follows:

 

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the 3D bioprinting market by technology (magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, microextrusion 3D bioprinting, and others), product (3D bioprinters, biomaterials, and scaffolds), material (living cells, extracellular matrices, hydrogels, and others), application (clinical applications, skin, bones, blood vessels, research applications, drug and medical research, regenerative medicine, and 3D cell culture), end use industry (pharmaceutical & biotechnology, research organizations & academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?